Adult Growth Hormone Deficiency Increases Medical Costs, Risk of Additional Health Conditions

August 9, 2022

Growth hormone deficiency (GHD) among adults is associated with greater medical costs and an increased rate of other health conditions compared with those without GHD, according to industry-sponsored research presented at ENDO 2022 in Atlanta. Researchers led by Alden Smith, PharmD, Global Head of Health Economics and Outcomes Research at Ascendis Pharma in Palo Alto, […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Growth Issues

←Endocrine Society Celebrates Passage of Historic Insulin Affordability Measure

A Light in the Darkness: Q&A with Karel Pacak, MD, PhD, DSc→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today